Skip to main content
. 2021 Mar 31;5(7):1837–1847. doi: 10.1182/bloodadvances.2020003453

Table 3.

Response evaluation

LDC* SDC Total P
First induction 83 100 183 .811
 CR 58 (69.9) 67 (67.0) 125 (68.3)
 PR 12 (14.5) 18 (18.0) 30 (16.4)
 NR 13 (15.6) 15 (15.0) 28 (15.3)
Second induction 80 96 176 .436
 CR 71 (88.8) 83 (86.4) 154 (87.5)
 PR 4 (5.0) 6 (6.3) 10 (5.7)
 NR 2 (2.5) 6 (6.3) 8 (4.5)
 Unavailable 3 (3.7) 1 (1.0) 4 (2.3)
Treatment-related deaths 1§ 2 3 1.000
 Induction I 0 0 0
 Induction II 1 (1.2) 2 (2.0) 3 (1.6)
Abandonment 7 7 14
 After induction I 3 (3.6) 4 (4.0) 7 (3.8) .912
 After induction II 4 (4.8) 3 (3.0) 7 (3.8)

All data are presented as n (%).

*

Twenty-two patients received 1 course of LDC for induction I and SDC for induction II.

Monte Carlo analysis was used for categorical variables with N×3 charts.

Two patients abandoned treatment and 1 patient in the LDC/SDC group died of treatment-related toxicity before evaluation of remission induction II; 1 patient died of treatment-related toxicity in the SDC group before evaluation of remission induction II.

§

Patient received LDC for induction I and SDC for induction II.